← Evidence map

ReviewPharmaceuticals (Basel, Switzerland)2023

Review on Bortezomib Resistance in Multiple Myeloma and Potential Role of Emerging Technologies.

Gül Kozalak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

34 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36678608